Clinical Trials Logo

Myocardial Ischemia clinical trials

View clinical trials related to Myocardial Ischemia.

Filter by:

NCT ID: NCT03102502 Completed - Clinical trials for Coronary Heart Disease

Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status

EECPVHS
Start date: March 10, 2017
Phase: N/A
Study type: Interventional

The present study aimed to investigated the effect of Enhanced External Counterpulsation (EECP) on vascular hemodynamics and atherosclerosis, and the underlying shear stress related mechanisms

NCT ID: NCT03102346 Recruiting - Clinical trials for Coronary Artery Disease

efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs

ASSIST
Start date: November 9, 2017
Phase: N/A
Study type: Interventional

Home-based CR (HBCR) was reported to improve the clinical outcomes of coronary artery disease (CAD) patients. There is no data published to investigate whether HBCR is also effective for Chinese CAD patients who have been revascularized. This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI (Percutaneous Coronary Intervention) procedure. This is a multicenter, randomized, controlled and observational study.

NCT ID: NCT03096158 Completed - Clinical trials for Coronary Artery Disease

Cardiac and Endothelial Function Response to Early Exercise Training After Coronary Artery Bypass Surgery

CEFREET
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Background: Coronary artery bypass grafting (CABG) due to coronary artery disease (CAD) is one of the main surgical procedures performed in the area of cardiology. Individuals undergoing CABG present sarcopenia, decreased muscle strength of the lower limbs, decreased respiratory muscle strength and dyspnea due to immobility in the bed and the inherent conditions of the disease itself. Cardiorespiratory rehabilitation techniques are rarely used with measurement in hospitals and can greatly favor an early and effective reestablishment to this population in several parameters. Objective: To evaluate the effect of functional electrical stimulation (FES), ventilatory muscle training (TREMVEN), early aerobic training (AERO) and isometric handgrip training (ISO) on the functional capacity, endothelial function and cardiac parameters of individuals undergoing CABG. Methods: In a randomized clinical trial, volunteers will be allocated into four groups: EEF, TREMVEN, AERO or ISO in the preoperative period of CABG. After 48 hours (postoperative midway) of the surgery, the protocol will begin until after hospital discharge. The endpoints evaluated will be: functional capacity, respiratory muscle strength, systolic and diastolic function, arterial endothelial function, inflammatory profile and plasma levels of vascular endothelial growth factor (VEGF). Scientific contributions: Phase 1 cardiorespiratory rehabilitation with alternative interventions may provide an increase in functional capacity, strengthening of respiratory muscles, improvement in cardiac and endothelial functions, as well as increased systemic VEGF levels (myocardial revascularization) and improvement of the inflammatory profile, effectively forwarding the individuals to the rehabilitation phase 2.

NCT ID: NCT03095469 Not yet recruiting - Heart Injuries Clinical Trials

Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

EODOPWCHD
Start date: August 20, 2017
Phase: Early Phase 1
Study type: Interventional

Coronary heart disease has a high incidence and high death rate. Percutaneous coronary intervention (PCI) is an important method for the treatment of coronary heart disease (CHD). However, PCI may cause myocardial cell injury and myocardial infarction 4 Type(MI4a, Type 4 a myocardial infarction related to PCI). Dexmedetomidine(Dex) is the only anesthetic which has sedative and analgesic effects. Dex currently has been widely used in perioperative management of various surgical.This study intends to verify the effect of heart protection of Dex in perioperative.

NCT ID: NCT03089450 Recruiting - Clinical trials for Ischemic Heart Disease

To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

Start date: March 22, 2017
Phase: N/A
Study type: Interventional

to evaluate safety and efficacy of CGBIO stent(DES) compared to Biomatrix flex stent(DES)

NCT ID: NCT03087292 Recruiting - Clinical trials for Coronary Artery Disease

Low Intensity Resistance Training With Vascular Occlusion in Coronary Heart Disease Patients

Start date: February 27, 2017
Phase: N/A
Study type: Interventional

In our clinical controlled trial, patients with coronary heart disease will be randomly assigned into the exercise intervention (low intensity resistance training with vascular occlusion) or usual physical activity group (control group).

NCT ID: NCT03087175 Completed - Clinical trials for Coronary Artery Disease

MGuard Stent and Microcirculation

GUARDIANCORY
Start date: December 2016
Phase: N/A
Study type: Interventional

NSTE-ACS represents the most frequent indication for coronary angiography and percutaneous coronary intervention (PCI) worldwide. PCI permit to reestablished coronary flow but effectiveness of PCI within thrombus containing lesions is limited by the risk of occurrence of distal embolization and no-reflow phenomenon. Distal embolization lead to coronary microcirculation lesions. This complication is related to poor prognosis. MGuard stent is a stainless-steel closed cell stent covered with an ultra-thin polymer mesh sleeve, which allows to prevent distal embolization during percutaneous coronary intervention in ST-segment-elevation myocardial infarction. Index of microcirculatory resistance (IMR) is a validated method to assess coronary microcirculation. Accordingly, the purpose of this study is to demonstrate that MGuard micronet mesh-covered stent prevent distal embolization and microvascular reperfusion impairment during primary PCI, compared with a bare metal stent (BMS) and drug eluting stent (DES) in patients with NSTE-ACS, assessed by Index of microcirculatory resistance.

NCT ID: NCT03085823 Completed - Clinical trials for Percutaneous Coronary Intervention

The All-comers Sirolimus-coated Balloon European Registry

EASTBOURNE
Start date: September 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to observe and evaluate the performance of a Sirolimus-eluting Drug Coated Balloon for the treatment of any type of coronary lesions, including native vessel disease and in stent restenosis.

NCT ID: NCT03083119 Recruiting - Clinical trials for Coronary Heart Disease

Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina

Start date: March 20, 2017
Phase: Phase 2
Study type: Interventional

In this study, typical cases of coronary heart disease are selected. They will be intervened by Xuesaitong soft capsules to investigate efficacy and safety for Coronary Heart disease.

NCT ID: NCT03082989 Completed - Myocardial Ischemia Clinical Trials

Evolving Routine Standards in Intracoronary Physiology

ERIS
Start date: March 13, 2017
Phase:
Study type: Observational [Patient Registry]

Italy is the European country with the minor penetration of FFR as compared to the number of percutaneous coronary intervention. Accordingly, the Società Italiana di Cardiologia Invasiva (SICI-GISE) conceived and promoted a prospective nationwide study to describe the patterns of the use of FFR in an unselected real-world population and to to assess the reasons, on clinical decision making, driving operators in the use or not of the FFR.